We just covered the
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Option Care Health (NASDAQ:OPCH) ranks #6 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller).
Druckenmiller’s Stake: $50,301,000
Option Care Health (NASDAQ:OPCH) provides home and outpatient infusion therapy services. It delivers medications like antibiotics and immune therapies directly to patients outside hospitals.
The stock has long-term potential because an aging population is increasing demand for ongoing treatments that don’t require hospital stays, which supports this shift toward home-based care.
Health systems are trying to reduce costs by moving care out of hospitals, and infusion-at-home services are usually cheaper than inpatient treatment. This would bode well for Option Care Health (NASDAQ:OPCH).
However, sentiment turned more cautious after Bank of America downgraded the stock from Buy to Neutral, following a cut to full-year guidance. The bank pointed to tougher insurance approvals and rising competition from pharmacy benefit managers and integrated pharmacy networks, and also lowered its price target sharply.
While we acknowledge the potential of OPCH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.